Fig. 7From: LC-MS/MS based metabolomics and proteomics reveal candidate biomarkers and molecular mechanism of early IgA nephropathyROC analysis in the validation set. The performance of the combined diagnostic model in the validation set was evaluated by ROC analysisBack to article page